Literature DB >> 35273416

Post COVID-19 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.

Daniela Ximena Rojas-Correa1, José Alberto Reche-Sainz1, Alfredo Insausti-García1, Cristina Calleja-García1, Manuel Ferro-Osuna1.   

Abstract

Neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relatively common. Although some may be consequences of direct cellular viral invasion (neurotropism), many represent post-infectious inflammation mediated by autoimmune mechanisms. We herein report the case of a 69-year-old diabetic male who presented with bilateral sub-acute, progressive loss of vision 45 days after suffering a presumed SARS-CoV-2 related pneumonia. He had bilateral optic disc oedema. Magnetic resonance imaging showed uniform contrast enhancement of both optic nerves without spinal cord involvement. He tested positive for SARS-CoV-2 IgG and myelin oligodendrocyte glycoprotein (MOG) IgG antibodies. He was treated with intravenous methylprednisolone for 5 days. The optic disc oedema resolved within 6 weeks with improvement in visual acuity, although optic atrophy developed by week 16. The MOG-IgG antibody test turned negative after 24 weeks.
© 2021 Taylor & Francis Group, LLC.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; myelin oligodendrocyte glycoprotein (MOG); optic neuritis

Year:  2021        PMID: 35273416      PMCID: PMC8903772          DOI: 10.1080/01658107.2021.1916044

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  14 in total

Review 1.  Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.

Authors:  John J Chen; M Tariq Bhatti
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

2.  Cranial neuropathies and COVID-19: Neurotropism and autoimmunity.

Authors:  Fiona Costello; Marinos C Dalakas
Journal:  Neurology       Date:  2020-06-02       Impact factor: 9.910

3.  A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.

Authors:  Masataka Nakamura; Yuko Iwasaki; Toshiyuki Takahashi; Kimihiko Kaneko; Ichiro Nakashima; Takenobu Kunieda; Satoshi Kaneko; Hirofumi Kusaka
Journal:  Mult Scler Relat Disord       Date:  2017-07-27       Impact factor: 4.339

Review 4.  Infectious optic neuropathies: a clinical update.

Authors:  Rim Kahloun; Nesrine Abroug; Imen Ksiaa; Anis Mahmoud; Hatem Zeghidi; Sonia Zaouali; Moncef Khairallah
Journal:  Eye Brain       Date:  2015-09-28

5.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.

Authors:  Siwei Zhou; Edward C Jones-Lopez; Deepak J Soneji; Christina J Azevedo; Vivek R Patel
Journal:  J Neuroophthalmol       Date:  2020-09       Impact factor: 3.042

6.  Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease in a 11 Year Old with COVID-19 Infection.

Authors:  Archana Khan; Hiren Panwala; Divya Ramadoss; Raju Khubchandani
Journal:  Indian J Pediatr       Date:  2021-01-20       Impact factor: 1.967

7.  False-negative results of initial RT-PCR assays for COVID-19: A systematic review.

Authors:  Ingrid Arevalo-Rodriguez; Diana Buitrago-Garcia; Daniel Simancas-Racines; Paula Zambrano-Achig; Rosa Del Campo; Agustin Ciapponi; Omar Sued; Laura Martinez-García; Anne W Rutjes; Nicola Low; Patrick M Bossuyt; Jose A Perez-Molina; Javier Zamora
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

Review 8.  Neurological associations of COVID-19.

Authors:  Mark A Ellul; Laura Benjamin; Bhagteshwar Singh; Suzannah Lant; Benedict Daniel Michael; Ava Easton; Rachel Kneen; Sylviane Defres; Jim Sejvar; Tom Solomon
Journal:  Lancet Neurol       Date:  2020-07-02       Impact factor: 44.182

9.  A systematic review of neurological symptoms and complications of COVID-19.

Authors:  Xiangliang Chen; Sarah Laurent; Finja Schweitzer; Clemens Warnke; Oezguer A Onur; Nina N Kleineberg; Gereon R Fink
Journal:  J Neurol       Date:  2020-07-20       Impact factor: 4.849

Review 10.  COVID-19 and the nervous system.

Authors:  Joseph R Berger
Journal:  J Neurovirol       Date:  2020-05-23       Impact factor: 3.739

View more
  6 in total

1.  Myelin-oligodendrocyte glycoprotein antibody-associated optic neuritis following SARS-CoV-2 pneumonia: A case report.

Authors:  Witoon Mitarnun; Theerawat Naksanguan; Nutchaya Laoharattanahirun; Patarasaya Roekrat; Suphakarn Kimavaha; Warut Kajornrith
Journal:  Neurol Clin Neurosci       Date:  2022-03-26

2.  Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: A case report and literature review.

Authors:  Buravej Assavapongpaiboon; Supanut Apinyawasisuk; Supharat Jariyakosol
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-17

Review 3.  COVID-19-associated optic neuritis - A case series and review of literature.

Authors:  Ajax Jossy; Ninan Jacob; Sandip Sarkar; Tanmay Gokhale; Subashini Kaliaperumal; Amit K Deb
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

Review 4.  Post COVID-19 neurological complications; a meta-analysis.

Authors:  Jaafar Omer Ahmed; Shwan Abdubakr Ahmad; Marwan Nasih Hassan; Fahmi H Kakamad; Rawezh Q Salih; Berwn A Abdulla; Fattah Hama Rahim Fattah; Shvan H Mohammed; Razhan K Ali; Abdulwahid M Salih
Journal:  Ann Med Surg (Lond)       Date:  2022-03-03

5.  SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder.

Authors:  Magnus Johnsson; Fredrik Asztely; Susanne Hejnebo; Markus Axelsson; Clas Malmeström; Torbjörn Olausson; Jan Lycke
Journal:  Ann Clin Transl Neurol       Date:  2022-06-17       Impact factor: 5.430

6.  COVID-19 and the risk of CNS demyelinating diseases: A systematic review.

Authors:  Itay Lotan; Shuhei Nishiyama; Giovanna S Manzano; Melissa Lydston; Michael Levy
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.